Ying‐Bei Chen

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma

  Cancer Cell · 2026-06-01

• Final results of a phase 2 trial of cabozantinib plus nivolumab (CaboNivo) in patients with non–clear cell renal cell carcinoma (nccRCC).

  Journal of Clinical Oncology · 2026-05-27

• Abstract LB294: Vhl-/-Tsc1-/-mice rapidly develop clear cell renal cell carcinoma with pronounced metabolic and redox reprogramming that necessitates NRF2 signaling

  Cancer Research · 2026-04-17

• Abstract B002: Vhl-/-Tsc1-/- mice rapidly develop clear cell renal cell carcinoma with pronounced metabolic and redox reprogramming that necessitates NRF2 signaling

  Cancer Research · 2026-03-13

• 906 L1CAM Expression by Immunohistochemistry Exhibits Complex Patterns and Different Diagnostic Utilities in Renal Epithelial Neoplasms

  Laboratory Investigation · 2026-03-01 · 1 citations

• 804 Immunohistochemical Assessment of DNA and Histone Methylation Markers in Testicular Germ Cell Tumor Correlates with Histologic Subtype and Response to Chemotherapy

  Laboratory Investigation · 2026-03-01

• 908 HER2 Expression Heterogeneity and ERBB2 Alterations in Urothelial Carcinoma: Implications for HER2-targeted Therapy

  Laboratory Investigation · 2026-03-01

• 768 Expression of Antibody-Drug Conjugate Targets on Neuroendocrine Carcinoma of the Bladder, and Association with Novel Neuroendocrine Markers

  Laboratory Investigation · 2026-03-01

• 769 Malignant Mesothelioma (MM) of Tunica Vaginalis (TV): Clinicopathological and Immunohistochemical Features with Molecular Correlation

  Laboratory Investigation · 2026-03-01

• 777 Genomic Characterization of Human Papillomavirus (HPV)-Associated Carcinoma of the Bladder

  Laboratory Investigation · 2026-03-01

• 900 Transcription Factor AP2-alpha (TFAP2A)-Mediated Distal Nephron Differentiation Links Sporadic and Von Hippel-Lindau (VHL)-Associated Clear Cell Papillary Renal Cell Tumors and Helps Differentiate Mimickers among Renal Cell Carcinomas with Fibromyomatous Stroma

  Laboratory Investigation · 2026-03-01

• 861 Assessing the Diagnostic Specificity of GPNMB Immunohistochemistry in Renal Epithelial Tumors

  Laboratory Investigation · 2026-03-01

• Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma

  Open Collections · 2026-01-01

• Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma

  Cancers · 2025-11-29

• Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

  European Urology Oncology · 2025-11-26 · 1 citations

• Hypoxia and tumor associated macrophages shape response to immune and angiogenesis-targeted therapies in metastatic clear cell renal cell carcinoma 3738

  The Journal of Immunology · 2025-11-01

• MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma

  European Urology · 2025-11-01

• Intratumoral early activated TCF1+ CD4 Th cells drive effector CD8 T cell responses in a novel sarcomatoid RCC model through anti-CTLA4 therapy 3951

  The Journal of Immunology · 2025-11-01

• 47TCF1+ CD4+ T cells mediate response to anti-CTLA-4 therapy in a sarcomatoid RCC mouse model

  The Oncologist · 2025-10-01

• 34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma

  The Oncologist · 2025-10-01